(3S)-3-[3-Bromo-5-(2-methyl-2-propanyl)phenyl]-3-[(N-{3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydro-2-pyrimidinyl)amino]benzoyl}glycyl)amino]propanoic acid(CAS: 1564286-55-0)

This compound is subject to GHS classification, REACH regulations, and may also be governed by FDA and EPA requirements for import and use in the United States. Specific safety data sheets (SDS) and material safety data sheets (MSDS) should be consulted for detailed guidelines on handling and disposal.

There are several alternatives depending on the specific synthetic route. Common substitutes include isomers, analogs such as (2S)-2-[3-Bromo-5-(2-methyl-2-propanyl)phenyl]-2-[(N-{3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydro-2-pyrimidinyl)amino]benzoyl}glycyl)amino]propanoic acid, and other reagents like 3-[(N-{3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydro-2-pyrimidinyl)amino]benzoyl}glycyl)amino]-3-[3-bromo-5-(2-methyl-2-propanyl)phenyl]propanoic acid.

The market trend for this compound is driven by increasing research in pharmaceutical applications, particularly in drug development. There is a growing interest in understanding its biological activities and potential uses as a pharmacological agent. Research trends focus on its effects on various target proteins and its therapeutic potential.

Waste containing this compound should be collected in a sealed container and disposed of according to local hazardous waste regulations. It is recommended to incinerate or use professional waste disposal services to ensure compliance with environmental protection standards. Proper labeling and documentation of the waste are essential to avoid contamination and ensure safety.